Finance

Beta
Lists
EQ:NASDAQ
Equillium Inc
$2.91
-4.28%
(-0.13) 1D
$2.91
+0.07% (+0.0021)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EQ...
Open
$3.06
High
$3.29
Low
$2.90
Mkt. cap
183.99M
Avg. vol.
1.03M
Volume
3.06M
52-wk high
$3.54
52-wk low
$0.29
EPS
-$0.32
Beta
1.77
Shares outstanding
63.23M
No. of employees
15
Open
$3.06
High
$3.29
Low
$2.90
Mkt. cap
183.99M
Avg. vol.
1.03M
Volume
3.06M
52-wk high
$3.54
52-wk low
$0.29
EPS
-$0.32
Beta
1.77
Shares outstanding
63.23M
No. of employees
15
News stories
From sources across the web
About Equillium Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Websiteequilliumbio.com
Analyst ratings
Based on 7 analysts giving stock ratings to EQ in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for EQ in the last 3 months.
Highest
Current $2.91
$12.00 (+312.37%)
Average
$7.57 (+160.14%)
Lowest
$5.00 (+71.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Walsh
Roth MKM
Buy
Maintained
$12.00
+312.4%
06/30/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$7.00
+140.5%
06/30/2026
William Wood
B. Riley Securities
Buy
Reiterated
$6.00
+106.2%
06/02/2026
Martin Auster
Raymond James
Buy
Maintained
$7.00
+140.5%
05/28/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
$5.00
+71.8%
05/28/2026
Thomas Smith
Leerink Partners
Buy
Upgraded
$6.00
+106.2%
05/28/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Initiated
$10.00
+243.6%
04/07/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$10.00
+243.6%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.08M
1.30M
1.54M
2.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.14M
3.27M
2.43M
2.62M
Operating expense
6.23M
4.58M
3.96M
5.61M
Total operating expenses
6.23M
4.58M
3.96M
5.61M
Operating income
-6.23M
-4.58M
-3.96M
-5.61M
Other non operating income
-
-
-
-
EBT including unusual items
-5.74M
-4.23M
-3.78M
-5.31M
EBT excluding unusual items
-5.74M
-4.23M
-3.78M
-5.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.74M
-4.23M
-3.78M
-5.31M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.06
-0.04
-0.06
Interest and investment income
122.00K
235.00K
303.00K
309.00K
Interest expense
-
-
-
-
Net interest expenses
122.00K
235.00K
303.00K
309.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.20M
-4.55M
-3.94M
-5.59M
Gain or loss from assets sale
-
-
19.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer